Brian Gelzheiser

US Director Of Sales at FH Ortho

Brian Gelzheiser has a strong background in sales, particularly in the medical industry. Brian began their career as a Sales Representative at Kimberly-Clark in 1999 before moving to Smith & Nephew as a Territory Sales Manager in 2000. Brian worked for Smith & Nephew for an impressive 13 years before transitioning to Wright/Tornier as a District Sales Manager in 2013. In 2016, Gelzheiser joined aap as the US Director of Sales, where they remained until 2019. Currently, Gelzheiser serves as the Director of Sales at FH Ortho.

Brian Gelzheiser attended Penn State University from 1990 to 1995, where they obtained a Bachelor of Science degree in Kinesiology and Exercise Science.

Location

Pittsburgh, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


FH Ortho

FH Ortho has been achieving rapid growth in the US orthopedic implant market, well-positioned as a surgeon-focused innovator and first-mover in areas of shoulder arthroplasty, calcaneal fracture fixation, and soft-tissue reconstructions in the knee. The Arrow® Prime Dual-Platform Shoulder System expands the options of the successful Arrow Universal Shoulder System, offering surgeons a cementless, metal-back anatomic glenoid option, with a clinically-proven design that addresses the most common failure modality in total shoulder arthroplasty; glenoid loosening. Supported by 14 years of successful clinical history, Arrow® Prime offers surgeons unparalleled intraoperative flexibility, dual-platform interchangeability, and addresses the continuum of indications for shoulder arthroplasty in an efficient, 4-tray instrument system. FH Ortho’s Calcanail® represents a novel, percutaneous approach for the treatment of calcaneal pathologies. An intramedullary nail, it offers a tissue-sparing approach for the address of tuberosity displacements, intra-articular fracture reduction, and arthrodesis when indicated. Coupled with advanced instrumentation, this guided-approach puts clinical efficacy and ease-of-use in the surgeon’s hands. The CoLS® system is a revolutionary approach to soft-tissue repair in the knee, engineered to counter principal short-comings that impact other methods. The CoLS® system is redefining the “gold standard” with short, precise tunnels, a pre-tensioned semitendinosus graft that guards against future laxity, and a robust method of fixation that favors healing. To learn more about Arrow® Prime, CoLS®, and Calcanail®, please visit www. fhortho.com.


Employees

11-50

Links